Version 2.77

Reference Information

Type Source Reference
Citation Regenstrief LOINC Parikh-Patel, Arti, et al. "Validation of self-reported cancers in the California Teachers Study." American journal of epidemiology 157.6 (2003): 539-545.

Fully-Specified Name

Component
In the past 3Y have you taken statins, lovastatin - mevacor, atorvastatin - lipitor, rosuvastain - crestor, pravastatin - pravachol, simvastatin - zocor, fluvastatin - lescol
Property
Find
Time
3Y
System
^Patient
Scale
Ord
Method
California Teachers Study

Additional Names

Short Name
Statins past 3Y 3Y CTS

Survey Question

Text
In the past 3 years, please indicate if you have taken either of the following types of medications. Statin medications such as lovastatin (Mevacor®), atorvastatin (Lipitor®), rosuvastain (Crestor®), pravastatin (Pravachol®), simvastatin (Zocor®), fluvastatin (Lescol®)
Source
PX071201030100

Normative Answer List: LL1133-9

Source: Consensus measures for Phenotypes and Exposures
Answer Code Score Answer ID
Yes, regularly (daily for at least 2 months) 1 LA14369-5
Yes, but not regularly 2 LA14370-3
NoCopyright http://snomed.info/sct ID:373067005 No (qualifier value) 3 LA32-8

Basic Attributes

Class
PHENX
Type
Clinical
First Released
Version 2.36
Last Updated
Version 2.65
Change Reason
Updated Time part to 3Y to reflect the exact look-back period stated in the question in order to provide internal consistency to the term [201508 LOINC Clinical Committee decision]; Updated Method from PhenX to reflect the original source of the content.; Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

Member of these Panels

LOINC Long Common Name
62557-4 PhenX domain - Cancer

Language Variants Get Info

Tag Language Translation
es-MX Spanish (Mexico) En los últimos 3 años, ¿ha tomado estatinas, lovastatina - mevacor, atorvastatina - lipitor, rosuvastatina - crestor, pravastatina - pravachol, simvastatina - zocor, fluvastatina - lescol:Tipo:3Años:^ Paciente:Ordinal:California Teachers Study
it-IT Italian (Italy) Negli ultimi 3 anni ha preso statine, lovastatina - Mevacor, atorvastatina - Lipitor, rosuvastatina - Crestor, pravastatina - Pravachol, simvastatina - Zocor, fluvastatina - Lescol:Osservazione:3 anni:^Paziente:Ord:California Teachers Study
Synonyms: CA Teachers Osservazione paziente PhenX
zh-CN Chinese (China) 在过去的那3年当中,您是否服用过他汀类药物,如洛伐他汀(美降脂)、阿托伐他汀(立普妥)、罗苏伐他汀(克来斯妥)、普伐他汀(普拉固)、辛伐他汀(舒降之)、氟伐他汀(来适可):发现:3年:^患者:序数型:加利福尼亚教师研究
Synonyms: CA Teachers;California Teachers Study;加利福尼亚州教师研究;加州教师研究 Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 lipitor;立普妥;阿伐他汀;阿妥伐他汀;阿活他汀 三年 依次型;分类顺序型;定性的;序数型(或称等级型);性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 加利福尼亚 加州 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 发现是一个原子型临床观察指标,并不是作为印象的概括陈述。体格检查、病史、系统检查及其他此类观察指标的属性均为发现。它们的标尺对于编码型发现可能是名义型,而对于叙述型文本之中所报告的发现,则可能是叙述型。;发现物;所见;结果;结论 在过去的那3年当中,您是否服用过他汀类药物,如洛伐他汀(lovastatin、洛弗斯塔特因、洛汀)(mevacor、美降脂、美降之)、阿托伐他汀(atorvastatin、阿活他汀)(lipitor、立普妥)、罗苏伐他汀(rosuvastain、瑞舒伐他汀)(crestor、克来斯妥)、普伐他汀(pravastatin、普伐他丁)(pravachol、普拉固)、辛伐他汀(simvastatin、斯伐他汀)(zocor、舒降之)、氟伐他汀(fluvastatin)(lescol、来适可、莱斯可) 普伐他丁;pravachol;普拉固;美百乐镇;萘维太定;帕伐他丁;怕瓦停普拉司丁;CAS 81093-37-0;C23H36O7;PRAVASELECT;ELISOR;EPTASTATIN SODIUM;(+)-(3R,5R)-3,5-二羟基-7-[(1S,2S,6S,8S,8aR)-6-羟基-2-甲基-8-[(S)-2-甲基丁酰氧基]-1,2,6,7,8,8a-六氢-1-萘]-庚酸;(BETAR, DELTAR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-BETA, 检查分析 氟伐地汀;富伐他丁;CAS 93957-54-1;C24H26FNO4;7-[3-(4-氟苯基)-1-(1-甲基乙基)-1H-吲哚-2-基]-3,5-二羟基-6-庚烯酸;7-[3-(4-氟苯基)-1-(1-甲基乙基)-1H-吲哚-2-基]-3,5-二羟基-6-庚烯酸钠 洛弗斯塔特因;洛汀;lovastatin;洛伐他丁;洛伐司他汀;罗伐他丁;洛凡司丁;洛伐它丁;第一代他汀类药物;乐瓦停;mevacor;美降脂;美降之;CAS 75330-75-5;C24H36O5;(1S,3R,7S,8S,8ΑR)-1,2,3,7,8,8Α-六氢-3,7-二甲基-8-[2.[(2R,4R)-四氢-4-羟基-6-氧代-2H-吡喃-2-基]乙基]-1-萘基(S)-2-甲基丁酸酯;(1S,3R,7S,8S,8ΑR)-1,2,3,7,8,8Α-HEXAHYDRO-3,7-DIMETHYL-8- 考察 调查 辛伐他丁;塞瓦停;斯伐他汀;西伐斯汀;辛伐司他汀;zocor;舒降之;l644128-000u;mk-0733;LIPONORM;CAS 79902-63-9;C25H38O5;EINECS 404-520-2; (1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-六氢-3,7-二甲基-8-[2-[(2R,4R)-四氢-4-羟基-6-氧代-2H-吡喃-2-基]乙基]-1-萘酚 2,2-二甲基丁酸酯;(1S,3R,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-3,7-DIM

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=63951-8